12/06/08

Cross-border malaria research rewarded in Africa

The money will go into further research, including final-stage trials of a malaria vaccine for children Copyright: Flickr/aheavens

By: Bibi-Aisha Wadvalla and Esther Tola and Christina Scott

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>Cross-border malaria research rewarded in Africa</h1>
<h4>By: Bibi-Aisha Wadvalla, Esther Tola and Christina Scott</h4>
</div>
<br />
<br />

<div id="article-body">
<p><span>Four African institutions carrying out malaria research have won an international cooperation award from the Prince of Asturias charitable foundation in Spain for their joint efforts. </span></p>
<p><span>The award, announced last month (28 May) and worth €50,000 (around US$77,000), went to Ghana’s Kintampo Health Research Centre, Mali’s Malaria Research and Training Centre, Mozambique’s Manhica Centre of Health Research and the Ifakara Health Research and Development Centre in Tanzania. They are scheduled to receive their awards in October this year.</span></p>
<p><span>The centres carry out biomedical research, vaccine trials, demography research and local training of personnel. </span></p>
<p><span>Ogobara Doumbo, director of the Mali centre, told SciDev.Net the award would help expand successful strategies such as insect-repellent mosquito nets and occasional (intermittent) preventative drug treatment for children and pregnant women.</span></p>
<p><span>About 80 researchers have been working on clinical trials of malaria vaccines at four sites in Mali since 2003, including molecular biologist Abdoulaye Djimdé, who developed simple techniques to monitor drug resistant malaria parasites from a drop of blood on filter paper.</span></p>
<p><span>Doumbo says they are now working on candidate vaccines targeting the early phase in the parasite’s life cycle in the human bloodstream.</span></p>
<p><span>The money will be ploughed straight back into further research, says John Aponte, head of the statistics unit at the Barcelona Hospital Clinic and a member of the team at the Manhiça Centre of Health Research. </span></p>
<p><span>Aponte said final-stage (phase three) trials of the RTS,S malaria vaccine for children under five years should begin in late 2008 or early 2009 at 11 centres in Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania. </span></p>
<p><span>Commentators say that the awards are a sign of Africa being at the forefront of solving African health problems.</span></p>
<p><span>"Mozambique and Africa are starting to lead the path toward solving their own health problems, and to deliver useful solutions to the rest of the world,” Graça Machel, president of nongovernmental organisation the Community Development Foundation in Maputo, who has worked with the Manhiça Centre for 12 years, said in a press statement.</span></p>
<p><span>”The work of the recipients reflects their respective commitment to cooperation across national and institutional boundaries — the type of cooperation that will be needed to effectively combat malaria at the global level,” said Christian Loucq, director of the PATH Malaria Vaccine Initiative, in a press statement.</span></p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/news/cross-border-malaria-research-rewarded-in-africa/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/news/cross-border-malaria-research-rewarded-in-africa/",null,true])
</script>
</div>

Four African institutions carrying out malaria research have won an international cooperation award from the Prince of Asturias charitable foundation in Spain for their joint efforts.

The award, announced last month (28 May) and worth €50,000 (around US$77,000), went to Ghana’s Kintampo Health Research Centre, Mali’s Malaria Research and Training Centre, Mozambique’s Manhica Centre of Health Research and the Ifakara Health Research and Development Centre in Tanzania. They are scheduled to receive their awards in October this year.

The centres carry out biomedical research, vaccine trials, demography research and local training of personnel.

Ogobara Doumbo, director of the Mali centre, told SciDev.Net the award would help expand successful strategies such as insect-repellent mosquito nets and occasional (intermittent) preventative drug treatment for children and pregnant women.

About 80 researchers have been working on clinical trials of malaria vaccines at four sites in Mali since 2003, including molecular biologist Abdoulaye Djimdé, who developed simple techniques to monitor drug resistant malaria parasites from a drop of blood on filter paper.

Doumbo says they are now working on candidate vaccines targeting the early phase in the parasite’s life cycle in the human bloodstream.

The money will be ploughed straight back into further research, says John Aponte, head of the statistics unit at the Barcelona Hospital Clinic and a member of the team at the Manhiça Centre of Health Research.

Aponte said final-stage (phase three) trials of the RTS,S malaria vaccine for children under five years should begin in late 2008 or early 2009 at 11 centres in Burkina Faso, Gabon, Ghana, Kenya, Malawi, Mozambique and Tanzania.

Commentators say that the awards are a sign of Africa being at the forefront of solving African health problems.

"Mozambique and Africa are starting to lead the path toward solving their own health problems, and to deliver useful solutions to the rest of the world,” Graça Machel, president of nongovernmental organisation the Community Development Foundation in Maputo, who has worked with the Manhiça Centre for 12 years, said in a press statement.

”The work of the recipients reflects their respective commitment to cooperation across national and institutional boundaries — the type of cooperation that will be needed to effectively combat malaria at the global level,” said Christian Loucq, director of the PATH Malaria Vaccine Initiative, in a press statement.